Cardiac toxicity in association with chemotherapy and radiation therapy in a large cohort of older patients with non-small-cell lung cancer

Dale Sharon Hardy, C. C. Liu, J. N. Cormier, R. Xia, X. L. Du

Research output: Contribution to journalArticle

53 Citations (Scopus)

Abstract

Background: The study's objective was to investigate the risks of developing cardiac disorders following the administration of chemotherapy and radiation therapy in patients with non-small-cell lung cancer (NSCLC). Methods: The study consisted of 34 209 patients aged ≥65 years with American Joint Committee on Cancer stages I-IV NSCLC identified from the Surveillance, Epidemiology, and End Result-Medicare linked database (1991-2002) who were free of cardiac disorders at NSCLC diagnosis. Results: There were significant associations between the use of chemotherapy/radiation and the risks of developing ischemic heart disease, conduction disorders, cardiac dysfunction, and heart failure. The absolute risks for cardiac dysfunction increased with the administration of chemotherapy-only and radiation-only, and incrementally with chemoradiation. Men, blacks, older patients, those with higher comorbidity scores, and advanced disease were at higher risk. The risk for ischemic heart disease increased when radiation/chemoradiation were rendered to the left lung and both lungs and for cardiac dysfunction, radiation administered to the left lung. Conclusions: There were significant associations especially for cardiac dysfunction with use of chemotherapy/radiation therapy and risks of developing cardiac toxicity in NSCLC patients. The risks of treatment-associated cardiac toxicity, specifically ischemic heart disease and cardiac dysfunction, were greatest among those with left-sided lung tumors.

Original languageEnglish (US)
Pages (from-to)1825-1833
Number of pages9
JournalAnnals of Oncology
Volume21
Issue number9
DOIs
StatePublished - Mar 8 2010

Fingerprint

Non-Small Cell Lung Carcinoma
Radiotherapy
Drug Therapy
Radiation
Myocardial Ischemia
Lung
Heart Failure
Medicare
Cardiotoxicity
Comorbidity
Neoplasms
Epidemiology
Databases

Keywords

  • Cardiac disorders
  • Chemotherapy
  • Lung cancer
  • Radiation therapy
  • Toxicit

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

Cardiac toxicity in association with chemotherapy and radiation therapy in a large cohort of older patients with non-small-cell lung cancer. / Hardy, Dale Sharon; Liu, C. C.; Cormier, J. N.; Xia, R.; Du, X. L.

In: Annals of Oncology, Vol. 21, No. 9, 08.03.2010, p. 1825-1833.

Research output: Contribution to journalArticle

Hardy, Dale Sharon ; Liu, C. C. ; Cormier, J. N. ; Xia, R. ; Du, X. L. / Cardiac toxicity in association with chemotherapy and radiation therapy in a large cohort of older patients with non-small-cell lung cancer. In: Annals of Oncology. 2010 ; Vol. 21, No. 9. pp. 1825-1833.
@article{4b205103ab3543c7972efdcda1080bb2,
title = "Cardiac toxicity in association with chemotherapy and radiation therapy in a large cohort of older patients with non-small-cell lung cancer",
abstract = "Background: The study's objective was to investigate the risks of developing cardiac disorders following the administration of chemotherapy and radiation therapy in patients with non-small-cell lung cancer (NSCLC). Methods: The study consisted of 34 209 patients aged ≥65 years with American Joint Committee on Cancer stages I-IV NSCLC identified from the Surveillance, Epidemiology, and End Result-Medicare linked database (1991-2002) who were free of cardiac disorders at NSCLC diagnosis. Results: There were significant associations between the use of chemotherapy/radiation and the risks of developing ischemic heart disease, conduction disorders, cardiac dysfunction, and heart failure. The absolute risks for cardiac dysfunction increased with the administration of chemotherapy-only and radiation-only, and incrementally with chemoradiation. Men, blacks, older patients, those with higher comorbidity scores, and advanced disease were at higher risk. The risk for ischemic heart disease increased when radiation/chemoradiation were rendered to the left lung and both lungs and for cardiac dysfunction, radiation administered to the left lung. Conclusions: There were significant associations especially for cardiac dysfunction with use of chemotherapy/radiation therapy and risks of developing cardiac toxicity in NSCLC patients. The risks of treatment-associated cardiac toxicity, specifically ischemic heart disease and cardiac dysfunction, were greatest among those with left-sided lung tumors.",
keywords = "Cardiac disorders, Chemotherapy, Lung cancer, Radiation therapy, Toxicit",
author = "Hardy, {Dale Sharon} and Liu, {C. C.} and Cormier, {J. N.} and R. Xia and Du, {X. L.}",
year = "2010",
month = "3",
day = "8",
doi = "10.1093/annonc/mdq042",
language = "English (US)",
volume = "21",
pages = "1825--1833",
journal = "Annals of Oncology",
issn = "0923-7534",
publisher = "Oxford University Press",
number = "9",

}

TY - JOUR

T1 - Cardiac toxicity in association with chemotherapy and radiation therapy in a large cohort of older patients with non-small-cell lung cancer

AU - Hardy, Dale Sharon

AU - Liu, C. C.

AU - Cormier, J. N.

AU - Xia, R.

AU - Du, X. L.

PY - 2010/3/8

Y1 - 2010/3/8

N2 - Background: The study's objective was to investigate the risks of developing cardiac disorders following the administration of chemotherapy and radiation therapy in patients with non-small-cell lung cancer (NSCLC). Methods: The study consisted of 34 209 patients aged ≥65 years with American Joint Committee on Cancer stages I-IV NSCLC identified from the Surveillance, Epidemiology, and End Result-Medicare linked database (1991-2002) who were free of cardiac disorders at NSCLC diagnosis. Results: There were significant associations between the use of chemotherapy/radiation and the risks of developing ischemic heart disease, conduction disorders, cardiac dysfunction, and heart failure. The absolute risks for cardiac dysfunction increased with the administration of chemotherapy-only and radiation-only, and incrementally with chemoradiation. Men, blacks, older patients, those with higher comorbidity scores, and advanced disease were at higher risk. The risk for ischemic heart disease increased when radiation/chemoradiation were rendered to the left lung and both lungs and for cardiac dysfunction, radiation administered to the left lung. Conclusions: There were significant associations especially for cardiac dysfunction with use of chemotherapy/radiation therapy and risks of developing cardiac toxicity in NSCLC patients. The risks of treatment-associated cardiac toxicity, specifically ischemic heart disease and cardiac dysfunction, were greatest among those with left-sided lung tumors.

AB - Background: The study's objective was to investigate the risks of developing cardiac disorders following the administration of chemotherapy and radiation therapy in patients with non-small-cell lung cancer (NSCLC). Methods: The study consisted of 34 209 patients aged ≥65 years with American Joint Committee on Cancer stages I-IV NSCLC identified from the Surveillance, Epidemiology, and End Result-Medicare linked database (1991-2002) who were free of cardiac disorders at NSCLC diagnosis. Results: There were significant associations between the use of chemotherapy/radiation and the risks of developing ischemic heart disease, conduction disorders, cardiac dysfunction, and heart failure. The absolute risks for cardiac dysfunction increased with the administration of chemotherapy-only and radiation-only, and incrementally with chemoradiation. Men, blacks, older patients, those with higher comorbidity scores, and advanced disease were at higher risk. The risk for ischemic heart disease increased when radiation/chemoradiation were rendered to the left lung and both lungs and for cardiac dysfunction, radiation administered to the left lung. Conclusions: There were significant associations especially for cardiac dysfunction with use of chemotherapy/radiation therapy and risks of developing cardiac toxicity in NSCLC patients. The risks of treatment-associated cardiac toxicity, specifically ischemic heart disease and cardiac dysfunction, were greatest among those with left-sided lung tumors.

KW - Cardiac disorders

KW - Chemotherapy

KW - Lung cancer

KW - Radiation therapy

KW - Toxicit

UR - http://www.scopus.com/inward/record.url?scp=77956118807&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=77956118807&partnerID=8YFLogxK

U2 - 10.1093/annonc/mdq042

DO - 10.1093/annonc/mdq042

M3 - Article

C2 - 20211871

AN - SCOPUS:77956118807

VL - 21

SP - 1825

EP - 1833

JO - Annals of Oncology

JF - Annals of Oncology

SN - 0923-7534

IS - 9

ER -